Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Vendramini ECL"'
Autor:
de Souza VH; Post Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Paraná, Brazil., de Alencar JB; Post Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Paraná, Brazil., Tiyo BT; Post Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Paraná, Brazil., Alves HV; Post Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Paraná, Brazil., Vendramini ECL; Post Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Paraná, Brazil., Sell AM; Post Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Paraná, Brazil.; Laboratory of Immunogenetics, Basic Health Sciences Department, State University of Maringá, Paraná, Brazil., Visentainer JEL; Post Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Paraná, Brazil.; Laboratory of Immunogenetics, Basic Health Sciences Department, State University of Maringá, Paraná, Brazil.
Publikováno v:
Oncotarget [Oncotarget] 2020 Sep 08; Vol. 11 (36), pp. 3405-3417. Date of Electronic Publication: 2020 Sep 08 (Print Publication: 2020).
Autor:
Tiyo BT; Laboratory of Immunogenetics, Department of Basic Health Sciences, Maringá State University (UEM), Maringá, Brazil., Vendramini ECL; Laboratory of Immunogenetics, Department of Basic Health Sciences, Maringá State University (UEM), Maringá, Brazil., de Souza VH; Laboratory of Immunogenetics, Department of Basic Health Sciences, Maringá State University (UEM), Maringá, Brazil., Colli CM; Laboratory of Immunogenetics, Department of Basic Health Sciences, Maringá State University (UEM), Maringá, Brazil., Alves HV; Laboratory of Immunogenetics, Department of Basic Health Sciences, Maringá State University (UEM), Maringá, Brazil., Sell AM; Laboratory of Immunogenetics, Department of Basic Health Sciences, Maringá State University (UEM), Maringá, Brazil., Zucoloto SBP; Inter-municipal Public Health Consortium (CISAMUSEP), Maringá, Brazil., Visentainer JEL; Laboratory of Immunogenetics, Department of Basic Health Sciences, Maringá State University (UEM), Maringá, Brazil.
Publikováno v:
Frontiers in immunology [Front Immunol] 2020 Sep 03; Vol. 11, pp. 1927. Date of Electronic Publication: 2020 Sep 03 (Print Publication: 2020).
Autor:
Nardin JM; Clinical Research Department, Erasto Gaertner Hospital, Curitiba, Brazil.; School of Health Science, UniBrasil, Curitiba, Brazil.; Pontifical Catholic University of Parana, Curitiba, Brazil., Schroth W; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Almeida TA; Clinical Oncology Department, Erasto Gaertner Hospital, Curitiba, Brazil., Mürdter T; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Picolotto S; Pharmacy Department, Erasto Gaertner Hospital, Curitiba, Brazil., Vendramini ECL; Pharmacy Department, Erasto Gaertner Hospital, Curitiba, Brazil., Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany., Kogin JP; School of Health Science, UniBrasil, Curitiba, Brazil., Miqueleto D; School of Health Science, UniBrasil, Curitiba, Brazil., de Moraes SDR; School of Health Science, UniBrasil, Curitiba, Brazil., Schwab M; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; Departments of Clinical Pharmacology, Pharmacy and Biochemistry, University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; iFIT Cluster of Excellence, University of Tuebingen, Tuebingen, Germany., Pecoits-Filho RF; Pontifical Catholic University of Parana, Curitiba, Brazil., Brauch H; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tuebingen, Tuebingen, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany.; iFIT Cluster of Excellence, University of Tuebingen, Tuebingen, Germany., Casali-da-Rocha JC; Pontifical Catholic University of Parana, Curitiba, Brazil.; Department of Oncogenetics, Erasto Gaertner Hospital, Curitiba, Brazil.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2020 Mar; Vol. 13 (2), pp. 284-292. Date of Electronic Publication: 2019 Nov 09.